Lympho Bob
A blog about Cancer in general, and Follicular Lymphoma in particular
Tuesday, February 27, 2024
Epcoritamab Gets FDA Priority Review
›
A quick bit of news: The FDA granted Priority Review status to Epcoritamab for Relapsed/Refractory Follicular Lymphoma. Epcoritamab is a bi...
Thursday, February 22, 2024
Survivorship Research
›
I've been thinking a lot about the idea of "survivorship" lately. In cancer terms, survivorship is what happens after treatme...
Friday, February 16, 2024
Upcoming LRF Event
›
As you may know, I like to promote some of the webinars and workshops the the LRF (the Lymphoma Research Foundation). I've been able to ...
2 comments:
Sunday, February 11, 2024
How to Read Survival Statistics
›
A couple of weeks ago, a reader made a comment about Overall Survival, and I gave a brief response. But I know there are some new readers he...
4 comments:
Sunday, February 4, 2024
World Cancer Day
›
Today is World Cancer Day , an event sponsored by the Union for International Cancer Control . In case you are wondering what "cancer c...
Tuesday, January 30, 2024
Treatment Options for Follicular Lymphoma
›
OncLive published another of their great video series a few weeks ago. I like these series -- they provide some very up-to-date information...
Thursday, January 25, 2024
New FDA Warning for CAR-T
›
There was some bad news for CAR-T treatments issued yesterday -- the FDA called for "Black Box Warning" for CAR-T treatments . T...
2 comments:
‹
›
Home
View web version